Use of antiepileptic drugs in bipolar disorder

Actas Espanolas de Psiquiatria

Volumn 34, Issue 1, 2006, Pages 55-64

  Perez Ceballos M A ^a   Vega Gil, N ^a   Sanchez M B ^a   Armijo, Juan A ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Antiepileptic drugs; Bipolar disorder; Rapid cycling

Indexed keywords

ANTICONVULSIVE AGENT;

BIPOLAR DISORDER; HUMAN; REVIEW; TREATMENT OUTCOME;

ANTICONVULSANTS; BIPOLAR DISORDER; HUMANS; TREATMENT OUTCOME;

EID: 33645036189     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Hirschfeld RMA, Bowden CL, Gitlin MJ, Keck PE, Perlis RH, Supess T, et al. Practice guideline for treatment of patients with bipolar disorder. Am J Psychiatry 2002;159:1-50.
2. Ballús C. Trastornos del estado de ánimo (afectivos). In: Farreras P, Rozman C, editors. Medicina Interna, 14 ed. Madrid: Mosby/Doyma, 2000; p. 1800-3.
3. Perils RH, Sachs GS, Lafer B, Otto MW, Stephen PD, Faraone SV, et al. Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data. Am J Psychiatry 2002;159:1155-9.
4. Nasrallah HA, Kuo I. Side effects in the treatment of bipolar affective disorder. Psychiatry Mental Health 2003;8.
5. Goodwin FK. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder. J Clin Psychiatry 2003;63(Suppl. 5):18-24.
6. Corbella B, Vieta E. Tratamientos en investigacion: nuevos antiepilépticos. http://www.psiquiatria.com/interpsiquis2001/2031.
7. Post R, Uhde T, Kramlinger K, Rubinow D. Carbamazepine treatment of mania: clinical and biochemical aspects. Clin Neuropharmacol 1986;9(Suppl. 4):547-9.
8. Ballenger JC, Post RM. Therapeutic effects of carbamazepine in affective illness: a preliminary report. Commun Psycopharmacol 1978;2:159-75.
9. Small JG, Klapper MH, Milstein V, Kellams JJ, Miller MJ, Marhenke JD, et al. Carbamazepine compared with lithium in the treatment of mania. Arch Gen Psychiatry 1991;48:915-21.
10. Lerer B, Moore N, Meyendorff E, Cho SR, Gershon S. Carbamazepine versus lithium in mania: a double-blind study. J Clin Psychiatry 1987;48:89-93.
11. Ballenger JC, Post RM. Carbamazepine in manic-depressive illness: a new treatment. Am J Psychiatry 1980;137:782-90.
12. Post RM, Unde TW, Roy-Byrne PP, Joffe RT. Antidepressant effects of carbamazepine. Am J Psychiatry 1986;143:29-34.
13. Dardennes R, Even C, Bange F, Heim A. Comparison of carbamazepine and lithium in the prophylaxis of bipolar disorders. A meta-analysis. Br J Psychiatry 1995;166:378-81.
14. Denicoff KD, Smith-Jackson EE, Disney ER, Ali SO, Leverich GS, Post RM. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry 1997;58:470-8.
15. Kleindienst N, Greil W. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study. Neuropsychobiology 2000;42(Suppl. 1):2-10.
16. Hartong EG, Moleman P, Hoogduin CA, Broekman TG, Nolen WA, LitCar Group. Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients. J Clin Psychiatry 2003;64:144-51.
17. Greil W, Kleindienst N. Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified, Int Clin Psychopharmacol 1999;14:283-5.
18. Okuma T. Effects of carbamazepine and lithium on affective disorders. Neuropsychobiology 1993;27:138-45.
19. Post RM, Uhde TW, Roy-Byrne PP, Joffe RT. Correlates of antimanic response to carbamazepine. Psychiatry Res 1987;21:71-83.
20. Post RM, Uhde TW, Ballenger JC, Squillace KM. Prophylactic efficacy of carbamazepine in manic-depressive illness. Am J Psychiatry 1983;140:1602-4.
21. Fawcett J. Valproate use in acute mania and bipolar disorder: an international perspective. J Clin Psychiatry 1989;50(Suppl.):10-2.
22. Petty F, Rush AJ, Davis JM, Calabrese JR, Kimmel SE, Kramer GL, et al. Plasma GABA predicts acute response to divalproex in mania. Biol Psychiatry 1996;39:278-84.
23. Macritchie K, Geddes JR, Scott J, Haslam D, de Lima M, Goodwin G. Valproate for acute mood episodes in bipolar disorder (Cochrane Review). In: The Cochrane Library, Issue 1, 2004. (Last update in September 2002).
24. Macritchie KAN, Geddes JR, Scott J, Haslam DRS, Goodwin GM. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder (Cochrane Review). In: The Cochrane Library, Issue 1, 2004. (Last update in March 2001).
25. Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, et al. A randomised placebo-controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry 2000;57:481-9.
26. Freeman TW, Clothier JL, Pazzaglia P, Lesem MD, Swann AC. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 1992;149:108-11.
27. Mondimore FM, Fuller GA, de Paulo JR. Drug combinations for mania. J Clin Psychiatry 2003;63(Suppl. 5):25-31.
28. Solomon DA, Ryan CE, Keitner GI, Miller IW, Shea MT, Kazim A, et al. A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with bipolar I disorder. J Clin Psychiatry 1997;58:95-9.
29. Bowden CL, Janicak PG, Orsulak P, Swann AC, Davis JM, Calabrese JR, et al. Relation of serum valproate concentration to response in mania Am J Psychiatry 1996;153:765-70.
30. Armijo JA, Herranz JL. Fármacos antiepilépticos y anticonvulsivos. En: Flórez J, Armijo JA, Mediavilla A, editores. Farmacología humana. Barcelona: Masson, 2003: p. 517-41.
31. Emrich HM, Altmann H, Dose M, von Zerssen D. Therapeutic effects of GABA-ergic drugs in affective disorders. A preliminary report. Pharmacol Biochem Behav 1983;19:369-72.
32. Emrich HM. Studies with oxcarbazepine (Trileptal) in acute mania, Int Clin Psychopharmacol 1990;5:83-8.
33. Zerjav-Lacombe S, Tabarsi E. Lamotrigine: a review of clinical studies in bipolar disorders. Can J Psychiatry 2001;46:328-33.
34. Pinzón A. Lamotrigina: evidencia de su utilidad en el trastorno bipolar. Medunar 2001;11:107-13.
35. Frye MA, Ketter TA, Kimbrell TA, Dunn RT, Speer AM, Osuch EA, et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000;20:607-14.
36. Anand A, Oren DA, Berman RM. Lamotrigine treatment of lithium failure in outpatient mania: a double blind, placebo controlled trial. In: Scares JC, Gershon S, editores. Abstract book of the third international bipolar conference Pittsburgh: Munksgaard, 1999; p. 23.
37. Ichim L, Berk M, Brook S. Lamotrigine compared with lithium in mania: a double blind randomized controlled trial. Ann Clin Psychiatry 2000;12:5-10.
38. Berk M. Lamotrigine and the treatment of mania in bipolar disorder. Euro Neuropsychopharmacol 1999;9(Suppl. 4):119-23.
39. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD, et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 1999;60:79-88.
40. Bowden CL, Calabrese JR, Sach G, Yatham LM, Asghar SA, Hompland M, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment on recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003;60:392-400.
41. Calabrese JR, Bowden CL, Sach G, Yatham LM, Behnke K, Mehtone OP, et al., Lamictal 605 Study Group. A placebo-controlled 18 month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003;64:1013-24.
42. Calabrese JR, Suppes T, Bowden CL, Sachs GS, Swann AC, McElroy SL, et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 2000;61:841-50.
43. Maidment ID. The use of topiramate in mood stabilization. Ann Pharmacother 2002;36:1277-81.
44. McIntyre RS, Mancini DA, McCann S, Srinivasan J, Sagman D, Kennedy SH. Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study. Bipolar Disord 2002;4:207-13.
45. Sachs GS, Kusherner SF, Wang D, Olson W, Capece J, Fazzio L, et al. Topiramate in adults with acute bipolar I mania: Pooled results. En: New Research and Abstracts, 2004 American Psychiatric Association Annual Meeting. Abstract NR365:135.
46. Fernández I, de Frutos MJ, Luján E, Ortiz del Romero J. Actualización en el tratamiento de pacientes cicladores rápidos y otros bipolares resistentes. Actas Esp Psiquiatr 2002;31:149-55.
47. Letterman L, Markowitz JS. Gabapentin: a review of published experience in the treatment of bipolar disorder and other psychiatric conditions. Pharmacotherapy 1999;19:565-72.
48. Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord 2000;2:249-55.
49. Goldberg JF, Burdick KE. Levetiracetam for acute mania. Am J Psychiatry 2002;159:148.
50. Braunig P, Kruger S. Levetiracetam in the treatment of rapid cycling bipolar disorder. J Psychopharmacol 2003;17:239-41.
51. Bazil CW. Antiepileptic drug in the 21st century. CNS Spectrums 2001;6:156-65.
52. Muzina DJ, El-Sayegh S, Calabrese JR. Antiepileptic drugs in psychiatry. Focus on randomised controlled trial. Epilepsy Res 2002;50:195-200.
53. Pope HG, McElroy SL, Keck PE, Hudson JI. Valproate in the treatment of acute mania: a placebo controlled study. Arch Gen Psychiatry 1991;48:62-8.
54. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, et al. Efficacy of divalproex vs. lithium and placebo in the treatment of mania. JAMA 1994;271:918-24.
55. McElroy SL, Keck PE, Stanton SP, Tugrul KC, Bennett JA, Strakowski SM. A randomised comparison of divalproex loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry 1996;57:142-6.
56. Muller-Oerlinghausen B; Retzow A, Henn FA, Giedke H, Walden J. Valproate add-on therapy in acute manic episodes. A prospective, randomised, double-blind, placebo-controlled multicentre study. J Clin Psychopharmacol 2000;20:195-203.
57. Vasudev K, Goswami U, Kohli K. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder. Psychopharmacology 2000;150:15-23.
58. Kowatch RA, Suppes T, Carmody TJ, Bucci JP, Hume JH, Kromelis M, et al. Effect size of lithium, divalproex, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2000;39:713-20.
59. Tohen M, Baker RW, Altshuler L, Zarate CA, Ketter TA, Milton DR, et al. Olanzapine versus divalproex for the treatment of acute mania. Stanley Foundation Conference on Bipolar Disorder. Amsterdam, September 21 and 22, 2000.
60. Zajecka JM, Weisler R, Sachs G, Swann AC, Wozniak P, Sommerville KW. A comparison of the efficacy, safety and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry 2002;63:1148-55.